11 employees
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
2015
$10M
from 5 investors over 5 rounds
Rational Vaccines raised undisclosed on March 8, 2022
Investors: Globivest
Rational Vaccines raised $10M on December 4, 2020
Investors: Founders Fund, Arab Angel Fund, Presight Capital and Thiel Capital